Compounds > zidovudine
Page last updated: 2024-08-23

zidovudine and Granulocytic Leukemia, Chronic

zidovudine has been researched along with Granulocytic Leukemia, Chronic in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Chen, C; Liu, F; Ma, W; Yuan, L; Zhao, C1
Moriyama, Y; Osman, Y; Shibata, A1
Darnowski, JW; Ottaviani, E; Tosi, P; Tura, S; Visani, G1
Cenacchi, A; Gamberi, B; Ottaviani, E; Tosi, P; Tura, S; Visani, G1
Bernard, P; Cony-Makhoul, P; Leng, B; Mahon, FX; Nabera, CB; Pellegrin, JL; Reiffers, J1
Blake, M; Chou, TC; Estrov, Z; Gutterman, JU; Kurzrock, R; Talpaz, M1

Other Studies

6 other study(ies) available for zidovudine and Granulocytic Leukemia, Chronic

ArticleYear
Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
    Oncology reports, 2020, Volume: 43, Issue:1

    Topics: beta Catenin; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Early Growth Response Protein 1; Emodin; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Wnt Signaling Pathway; Zidovudine

2020
Enhanced elimination of Ph+ chromosome cells in vitro by combined hyperthermia and other drugs (AZT, IFN-alpha, TNF, and quercetin): its application to autologous bone marrow transplantation for CML.
    Experimental hematology, 1995, Volume: 23, Issue:5

    Topics: Apoptosis; Bone Marrow Purging; Bone Marrow Transplantation; Drug Synergism; Hot Temperature; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplastic Stem Cells; Quercetin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Zidovudine

1995
Hydroxyurea enhances 3'-azido-3'-deoxythymidine (AZT) cytotoxicity in human chronic myeloid leukemia models.
    European journal of haematology, 1994, Volume: 52, Issue:5

    Topics: Bone Marrow; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Synergism; Humans; Hydroxyurea; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Tumor Cells, Cultured; Zidovudine

1994
Synergistic cytotoxicity of AZT plus alpha and gamma interferon in chronic myeloid leukemia cell line K562.
    European journal of haematology, 1993, Volume: 51, Issue:4

    Topics: Cell Division; Cell Line; Cell Survival; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Humans; Interferon alpha-2; Interferon-alpha; Interferon-gamma; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recombinant Proteins; Thymidine; Tumor Cells, Cultured; Zidovudine

1993
Improving the cytogenetic response to interferon alpha by zidovudine (AZT) in an HIV-positive chronic myelogenous leukemia patient.
    Leukemia & lymphoma, 1997, Volume: 26, Issue:1-2

    Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Drug Therapy, Combination; Hematologic Tests; HIV Seropositivity; Humans; Interferon Type I; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Recombinant Proteins; Zidovudine

1997
Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia.
    Leukemia, 1991, Volume: 5, Issue:2

    Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Synergism; Erythroid Precursor Cells; Female; Hematopoiesis; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Interferon Type I; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Zidovudine

1991